Search Your Queries Related To Trilegal
Update

Competition Commission of India issues revised FAQs on merger control

23 May 2025

Competition Commission of India issues revised FAQs on merger control

Marking its 16th Annual Day on 20 May 2025, the CCI introduced a revised edition of the FAQs on combinations. These highly anticipated revisions to the FAQs were needed to bring clarity in the interpretation of the recently overhauled merger control regime in India.

Partners: Aparna Mehra, Gauri Chhabra, Gautam Chawla and Rudresh Singh

The Competition Amendment Act, 2023 (Amendment), introduced several changes to the Indian merger control regime. Key reforms include (i) the introduction of deal value thresholds (DVT), (ii) codification of the ‘material influence’ standard of control, (iii) shorter approval timelines, and (iv) derogation from suspensory obligations for open offers or public market acquisitions, amongst other significant changes. These changes, with the implementing regulations (Regulations), came into effect in September 2024. (To read our detailed update on the Amendment, click here.)

Drawing on nine months of implementation experience and the need for clearer guidance for stakeholders, the Competition Commission of India (CCI) has released revised Frequently Asked Questions (FAQ) which interpret the amended provisions and Regulations. The CCI’s efforts in bringing clarity to the merger control regime are a welcome step to promote transparency amongst all stakeholders. However, it is important to note that these FAQs have been published as a part of the CCI’s advocacy and awareness initiatives and are not meant to be considered as the CCI’s official views. Accordingly, they are not binding and are only intended to serve as guidance.

Key highlights of the FAQs and their impact

  1. Control
  2. The Amendment codified the ‘material influence’ standard for determining control under the Amendment. However, the distinction between investor protection rights and control-conferring rights remained unclear. Through the FAQs, the CCI draws on its decisional practice to provide an indicative list of rights that are generally viewed as conferring control. This guidance is broadly in alignment with the guidance provided by the European Commission on this issue.

    Control-Conferring Rights Investor Protection Rights (generally not considered control-conferring)
    1. Appointment or removal of senior management personnel;
    2. approval of budget;
    3. approval of business plans;
    4. alteration of charter documents which directly or indirectly affects the day-to-day operational dynamics; and
    5. any right relating to operational parameters, namely, research & development, manufacturing, marketing, general day-to-day administration, etc.
    1. Information rights;
    2. right to ensure investment amount is utilised in accordance with agreed contractual terms or business plan;
    3. exit rights;
    4. tag along rights;
    5. anti-dilution rights;
    6. rights restricting transfer of shares to particular identified persons or enterprises;
    7. alteration of charter documents as regards adverse changes in other rights of the investor which are agreed between the parties; and
    8. right to appoint an observer.

    As ‘control’ is an integral principle in assessing notification requirements, availability of exemptions and overlap mapping, the guidance issued by CCI will help to provide clarity on which rights are control-conferring rights and which rights are mere investor protection rights.

  3. Deal value thresholds
  4. A key change introduced by the Amendment was the introduction of the DVT. A transaction with a deal value exceeding INR 2,000 crore (~ USD 234 million) will require a prior merger notification filing to the CCI, provided the target or the merging parties have substantial business operations in India. The DVT was introduced to expand the CCI’s oversight of M&A activity, especially in the digital economy, which may escape traditional asset or turnover-based thresholds.

    While the Regulations provide the framework for calculation of the DVT, its application has raised several interpretive questions, necessitating further guidance. The FAQs now provide guidance on the computation and applicability of the DVT, covering key aspects relevant for determining the value of a transaction, as discussed below.

    1. Call options are treated as shares and must be included in the value of the transaction at the time of acquisition. This includes both the option premium and the exercise price, unless such options vest with the acquirer more than two years from the date of signing. Notably, the value of call options that vest upon the holder only at the occurrence or non-occurrence of an event outside the control of contracting parties are excluded from the deal value computation.
    2. Put options are not considered as acquisition of shares, and therefore excluded from the value of the transaction for the purpose of triggering notification requirements.
    3. For share swaps, the value of the transaction will include the aggregate value of both the share acquisitions.
    4. Where a seller remains a key managerial personnel in the target enterprise post-closing and is contractually entitled to additional payments based on the company meeting certain targets, the estimated value of such payments must be included in the transaction value. The value of such payments should be based on the best estimate approved by the board or relevant authority. If no estimate is recorded, the maximum possible payout must be considered.

  5. Inter-connected transactions
  6. The regulations provide that where the ultimate intended outcome of a transaction is achieved through a series of interconnected steps, the parties must file a single notice, covering all steps, including those that might be otherwise exempt, before the CCI. The standstill obligation – which prevents parties from closing the transaction until CCI approval is received – will consequently apply to all interconnected transaction steps.

    Through its decisional practice, the CCI has in the past indicated that factors, such as (i) commonality of business and parties involved, (ii) simultaneous negotiation, execution and consummation of the transaction, (iii) common board approvals or press releases, etc., and (iv) commercial feasibility of isolating the transactions, are relevant to determine whether two or more transactions are inter-connected.

    In an industry-friendly move, the FAQs now clarify that the key consideration for ‘inter-connection’ is whether there is a shared intent or a mutual understanding – a meeting of minds – between parties over the decision to invest in the same entity.

    The existence of separate agreements alone will not be a determination of interconnection. If two investors have separate transaction documents but other factors exist, such as their investments being mutually conditional, through conditions precedent or subsequent, this can indicate dependent transactions and economic inseparability.

    Businesses are likely to embrace this clarification from the CCI. It significantly simplifies compliance by alleviating the regulatory burden on parties whose transactions were independent and limiting it to those which are based on genuine commercial interdependence or a shared decision to invest.

  7. Commercially sensitive information
  8. Another key change introduced by the Amendment was a revised definition of ‘affiliate’ to include entities that have the right or ability to access commercially sensitive information (CSI) of another enterprise in addition to the shareholding or board representation criteria.

    The expanded ‘affiliate’ test is important for identifying overlaps between the activities of parties, which in turn impact the applicability of key aspects of merger control, such as the availability of several exemptions and the ‘Green Channel’ route. The Green Channel is available if the parties, their respective group entities and/or their ‘affiliates’ have no overlaps, and the notified transaction is deemed approved on the day of the filing.

    However, the Regulations did not define what constitutes CSI, leading to ambiguity for businesses and legal advisors. For example, it is unclear whether routine investor rights, such as access to unaudited financial statements, will qualify an entity as an affiliate.

    To address these ambiguities, the CCI has provided a non-exhaustive, indicative list of what information is and is not considered as CSI.

    Information considered to be CSI by the CCI Information not considered to be CSI by the CCI
    1. Pricing, sales, market share, etc.;
    2. capacity, output, quality, etc.;
    3. budgets, annual business plan, minutes of board meetings;
    4. innovation, pipeline products, research and development, etc.; and
    5. strategic plans, such as marketing plans, plans to enter or exit a market, promotional plans, etc.
    1. Unaudited (monthly, quarterly, annual) or audited financial statements made in accordance with GAAP, provided they only contain information that audited financial statements contain;
    2. information which is available to an ordinary shareholder and historical data;
    3. publicly disclosed information or information which is readily ascertainable through appropriate means;
    4. information that cannot be linked to a specific company; and
    5. ownership structure.

  9. Open offer
  10. The Amendment allows derogation from suspensory obligations for open offers or public market acquisitions. Specifically, such transactions will no longer attract gun jumping penalties if:

    1. they are notified to the CCI within 30 days from the date of the first acquisition of shares, following the implementation of the open offer, and
    2. only mere economic benefits (such as dividends, bonus shares, stock-splits, etc.) are exercised while voting rights are limited to matters relating to liquidation or insolvency.

    While the intent of the Amendment was to allow derogation from the suspensory regime for all secondary market acquisitions on the stock exchange, there was ambiguity as to whether block and bulk deals, which are negotiated in advance but implemented on the stock exchange, would be eligible for this benefit.

    The FAQs now clarify that block deals and bulk deals will also benefit from the derogation as they relate to secondary acquisition of shares through the stock exchange. However, preferential allotment of shares, which involves the preferential issuance of fresh shares, results in a primary acquisition and may not benefit from the derogation.

    This clarification is particularly relevant for entities looking for open-market share acquisitions including hostile takeovers, which may be made without the target enterprise’s consent, since such transactions will not automatically trigger gun jumping proceedings.

Conclusion

The FAQs also provide additional guidance, for instance, on the methodology to be used to assess overlaps and determine the ‘ultimate controlling person’. The publication of the revised FAQs underscores the CCI’s proactive stance in providing clarity and transparency, despite the fact that it is not the official view of the CCI. The FAQs are a living tool which will evolve based on experience gained through the implementation of the law.


If you require any further information about the material contained in this newsletter, please get in touch with your Trilegal relationship partner or send an email to alerts@trilegal.com. The contents of this newsletter are intended for informational purposes only and are not in the nature of a legal opinion. Readers are encouraged to seek legal counsel prior to acting upon any of the information provided herein.

Subscribe to our Knowledge Repository

If you would like to receive content directly in your inbox from our knowledge repository, please complete this subscription form. This service is reserved for clients and eligible contacts.







    Let's connect

    Disclaimer

    Under the rules of the Bar Council of India, Trilegal is prohibited from soliciting work or advertising in any form or manner. By accessing this website, www.trilegal.com, you acknowledge that:

    • You are seeking information about Trilegal of your own accord and there has been no form of solicitation, advertisement or inducement by Trilegal or its members.
    • This website should not be construed as providing legal advice for any purpose.
    • All information, content, and materials available on this website are for general informational purposes only.
    • Any information obtained or material downloaded from this website is completely at the user’s volition, and any transmission, receipt or use of this website is not intended to, and will not, create any lawyer-client relationship.
    • Information on this website may not constitute the most up-to-date legal or other information. Trilegal is not liable for the consequences of any action taken by any person based on any material or information available on this website, or for any inaccuracy in or exclusion of any information or interpretation thereof.
    • Readers of this website or recipients of content or information available on this website should not act based on any or all such content or information, and should always seek advice of competent legal counsel licensed to practice in the appropriate jurisdiction.
    • Third party links contained on this website re-directing users to such third-party websites should neither be construed as legal reference / legal advice, nor considered as referrals to, endorsements of, or affiliations with, any such third party website operators.
    • The communication platform provided on this website should not be used for exchange of any confidential, business or politically sensitive information.
    • The contents of this website are the intellectual property of Trilegal.

    We prioritize your privacy. Before proceeding, we encourage you to read our privacy policy, which outlines the below, and terms of use to understand how we handle your data:

    • The types of information we collect and why we collect them.
    • How we use your information to provide a personalized experience.
    • The measures we take to ensure the security of your data.
    • Your rights and choices in managing your personal information.
    • How we may share information with trusted partners for specific purpose.

    For more information, please read our terms of use and our privacy policy.

    Up arrow